For US Healthcare Professionals
|
COZAAR® (losartan potassium tablets)
(See Boxed Warning on use in pregnancy in Prescribing Information) |
|
| EMEND® (fosaprepitant dimeglumine) for Injection |
|
HYZAAR® (losartan potassium-hydrochlorothiazide tablets)
(See Boxed Warning on use in pregnancy in Prescribing Information) |
|
JANUMET® (sitagliptin/metformin HCl) tablets
(Please read the Boxed Warning about lactic acidosis in the Prescribing Information.) |
|
| MAXALT® (rizatriptan benzoate) Tablets |
|
| MAXALT-MLT® (rizatriptan benzoate) Orally Disintegrating Tablets |
|
Merck/Schering-Plough Pharmaceuticals
| VYTORIN® (ezetimibe/simvastatin) Tablets |
|
| ZETIA® (ezetimibe) Tablets |
|
This is not a complete list of Merck products. For a full listing of Merck products, please visit Prescribing Information for all Merck Products.
|
Ask a Product-Related Question or Report an Adverse Event
Let us assist you with information and services related to Merck and its products.
Get Started
The Merck National Service Center will be pleased to assist you Monday–Friday from 8:00 AM–7:00 PM ET. Adverse events and product-related emergencies will be handled at any time.
|
|
COZAAR and HYZAAR are registered trademarks of E.I. du Pont de Nemours and Company, Wilmington, Delaware, USA
VYTORIN and ZETIA are registered trademarks of MSP Singapore Company, LLC.
View the Merck/Schering-Plough privacy policy.
All other brand names are registered trademarks or trademarks of Merck & Co., Inc.
MerckServices, MerckSource, and Merck OnCall are registered trademarks of Merck & Co., Inc.
MerckProductServices and MerckMedicus are trademarks of Merck & Co., Inc.
|
|
|
|
